Immunorizon
France
acquiredunknown
unknown
Stage
2023
Founded
1
Investors
About
Immunorizon is a biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. Their lead program focuses on a first-in-class antagonist of the IL-7 receptor.
Explore Immunorizon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.